Current role
Kristen Buck
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Lisata Therapeutics, Inc. (LSTA)
Proxy statement
Current -
Lisata Therapeutics, Inc. (LSTA)
Proxy statement
Start not stated–2026-08-03
Company network
Recorded roles and earnings-call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | Lisata Therapeutics, Inc. (LSTA) | M.D, Executive Vice President of Research & Development and Chief Medical Officer | $597,421 | $1,065,061 |
| 2023 | Lisata Therapeutics, Inc. (LSTA) | M.D, Executive Vice President of Research & Development and Chief Medical Officer | $574,443 | $969,817 |
| 2022 | Lisata Therapeutics, Inc. (LSTA) | M.D, Executive Vice President of Research & Development and Chief Medical Officer | $553,781 | $1,124,102 |
| 2021 | Lisata Therapeutics, Inc. (LSTA) | M.D, Executive Vice President of Research & Development and Chief Medical Officer | $183,333 | $1,858,333 |
Recent activity
No earnings-call appearances or filed executive changes recorded yet.